Literature DB >> 24005765

Serum n-3 to n-6 polyunsaturated fatty acids ratio correlates with coronary plaque vulnerability: an optical coherence tomography study.

Takao Hasegawa1, Kenichiro Otsuka, Tomokazu Iguchi, Kenji Matsumoto, Shoichi Ehara, Shinji Nakata, Satoshi Nishimura, Toru Kataoka, Kenei Shimada, Minoru Yoshiyama.   

Abstract

A low ratio of eicosapentaenoic acid to arachidonic acid (EPA/AA) has been demonstrated to be associated with a higher risk of cardiovascular events. Optical coherence tomography (OCT) is useful for the assessment of coronary plaque vulnerability. The purpose of this study was to evaluate the association between EPA/AA ratio and coronary plaque vulnerability. This study involved 58 patients with stable angina pectoris undergoing percutaneous coronary intervention. OCT image acquisition was performed before the procedure in the culprit lesions. We assessed lipid-rich plaque length and arc, fibrous cap thickness, frequency of thin-cap fibroatheroma (TCFA), thrombus, ruptured plaque, macrophage infiltration, and microvessels using OCT. Patients were divided into two groups according to the median value of serum EPA/AA ratio: a low-EPA/AA group (n = 29, EPA/AA ratio <0.36) and a high-EPA/AA group (n = 29, EPA/AA ratio ≥0.36). In qualitative analyses, TCFA (35.4 vs 6.9 %, P = 0.0095), macrophage infiltration (48.3 vs 13.8 %, P = 0.0045), and microvessels (44.8 vs 10.3 %, P = 0.0033) were more frequently observed in the low-EPA/AA group. In quantitative analyses, the low-EPA/AA group had wider maximum lipid arc (114.0 ± 94.8° vs 56.4 ± 66.0°, P = 0.0097), longer lipid length (4.8 ± 4.5 vs 1.6 ± 2.6 mm, P = 0.0037), and thinner fibrous cap (69.3 ± 28.3 vs 113.3 ± 46.6 μm, P = 0.005) compared with the high-EPA/AA group. EPA/AA ratio was positively correlated with fibrous cap thickness (r = 0.46, P = 0.007). In a multivariate model, an EPA/AA ratio <0.36 was associated with the presence of TCFA (odds ratio 6.41, 95 % confidence interval 1.11-61.91, P = 0.0371). In our detailed OCT analysis, lower EPA/AA ratio was associated with higher vulnerability of coronary plaques to rupture.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24005765     DOI: 10.1007/s00380-013-0404-4

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  28 in total

Review 1.  Intensive lipid-lowering therapy in patients with coronary heart disease.

Authors:  Stacy A Lauderdale; Amy Heck Sheehan
Journal:  Ann Pharmacother       Date:  2004-12-21       Impact factor: 3.154

2.  Intracoronary optical coherence tomography and histology at 1 month and 2, 3, and 4 years after implantation of everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: an attempt to decipher the human optical coherence tomography images in the ABSORB trial.

Authors:  Yoshinobu Onuma; Patrick W Serruys; Laura E L Perkins; Takayuki Okamura; Nieves Gonzalo; Hector M García-García; Evelyn Regar; Marika Kamberi; Jennifer C Powers; Richard Rapoza; Heleen van Beusekom; Willem van der Giessen; Renu Virmani
Journal:  Circulation       Date:  2010-10-25       Impact factor: 29.690

Review 3.  Inflammation in atherosclerosis.

Authors:  Peter Libby
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-09       Impact factor: 8.311

4.  Are our tools for the identification of TCFA ready and do we know them?

Authors:  Renu Virmani
Journal:  JACC Cardiovasc Imaging       Date:  2011-06

5.  Effects of lipid-lowering therapy with strong statin on serum polyunsaturated fatty acid levels in patients with coronary artery disease.

Authors:  Satoshi Kurisu; Ken Ishibashi; Yasuko Kato; Naoya Mitsuba; Yoshihiro Dohi; Kenji Nishioka; Yasuki Kihara
Journal:  Heart Vessels       Date:  2011-12-21       Impact factor: 2.037

6.  Ratio of serum n-3 to n-6 polyunsaturated fatty acids and the incidence of major adverse cardiac events in patients undergoing percutaneous coronary intervention.

Authors:  Takenori Domei; Hiroyoshi Yokoi; Shoichi Kuramitsu; Yoshimitsu Soga; Takeshi Arita; Kenji Ando; Shinichi Shirai; Katsuhiro Kondo; Koyu Sakai; Masahiko Goya; Masashi Iwabuchi; Masayuki Ueeda; Masakiyo Nobuyoshi
Journal:  Circ J       Date:  2011-12-08       Impact factor: 2.993

7.  Association of serum levels of arachidonic acid and eicosapentaenoic acid with prevalence of major adverse cardiac events after acute myocardial infarction.

Authors:  Masayuki Ueeda; Takenori Doumei; Yoichi Takaya; Nobuhiko Ohnishi; Atsushi Takaishi; Satoshi Hirohata; Toru Miyoshi; Ryoko Shinohata; Shinichi Usui; Shozo Kusachi
Journal:  Heart Vessels       Date:  2010-10-21       Impact factor: 2.037

Review 8.  The role of marine omega-3 (n-3) fatty acids in inflammatory processes, atherosclerosis and plaque stability.

Authors:  Philip C Calder
Journal:  Mol Nutr Food Res       Date:  2012-07       Impact factor: 5.914

9.  Blood levels of long-chain n-3 fatty acids and the risk of sudden death.

Authors:  Christine M Albert; Hannia Campos; Meir J Stampfer; Paul M Ridker; JoAnn E Manson; Walter C Willett; Jing Ma
Journal:  N Engl J Med       Date:  2002-04-11       Impact factor: 91.245

Review 10.  Immunology of ischemic vascular disease: plaque to attack.

Authors:  John M Hallenbeck; Göran K Hansson; Kyra J Becker
Journal:  Trends Immunol       Date:  2005-10       Impact factor: 16.687

View more
  10 in total

1.  Unusual peri-stent strut contrast staining 6 years after sirolimus-eluting stent implantation: an "ant colony-like" appearance.

Authors:  Yoji Neishi; Hiroyuki Okura; Kiyoshi Yoshida
Journal:  Heart Vessels       Date:  2013-11-07       Impact factor: 2.037

2.  Usefulness of pre- and post-stent optical frequency domain imaging findings in the prediction of periprocedural cardiac troponin elevation in patients with coronary artery disease.

Authors:  Kenichiro Otsuka; Kenei Shimada; Hirotoshi Ishikawa; Haruo Nakamura; Hisashi Katayama; Hisateru Takeda; Kohei Fujimoto; Noriaki Kasayuki; Minoru Yoshiyama
Journal:  Heart Vessels       Date:  2019-09-27       Impact factor: 2.037

3.  Coronary plaque rupture with subsequent thrombosis typifies the culprit lesion of non-ST-segment-elevation myocardial infarction, not unstable angina: non-ST-segment-elevation acute coronary syndrome study.

Authors:  Mikumo Sakaguchi; Shoichi Ehara; Takao Hasegawa; Kenji Matsumoto; Satoshi Nishimura; Junichi Yoshikawa; Kenei Shimada
Journal:  Heart Vessels       Date:  2016-06-21       Impact factor: 2.037

4.  Effect of purified eicosapentaenoic acid on red cell distribution width in patients with ischemic heart disease.

Authors:  Masao Takahashi; Masahiro Myojo; Aya Watanabe; Arihiro Kiyosue; Koichi Kimura; Jiro Ando; Yasunobu Hirata; Issei Komuro
Journal:  Heart Vessels       Date:  2014-05-31       Impact factor: 2.037

5.  New insights into spotty calcification and plaque rupture in acute coronary syndrome: an optical coherence tomography study.

Authors:  Mikumo Sakaguchi; Takao Hasegawa; Shoichi Ehara; Kenji Matsumoto; Kazuki Mizutani; Tomokazu Iguchi; Hideshi Ishii; Masashi Nakagawa; Kenei Shimada; Minoru Yoshiyama
Journal:  Heart Vessels       Date:  2016-03-05       Impact factor: 2.037

6.  Aberrant serum polyunsaturated fatty acids profile is relevant with acute coronary syndrome.

Authors:  Atsushi Sakamoto; Masao Saotome; Natsuko Hosoya; Shigetaka Kageyama; Toru Yoshizaki; Ryosuke Takeuchi; Koichiro Murata; Ryuzo Nawada; Tomoya Onodera; Akinori Takizawa; Hiroshi Satoh; Hideharu Hayashi
Journal:  Heart Vessels       Date:  2015-08-02       Impact factor: 2.037

7.  Determinants of Non-calcified Low-Attenuation Coronary Plaque Burden in Patients Without Known Coronary Artery Disease: A Coronary CT Angiography Study.

Authors:  Hiroki Yamaura; Kenichiro Otsuka; Hirotoshi Ishikawa; Kuniyuki Shirasawa; Daiju Fukuda; Noriaki Kasayuki
Journal:  Front Cardiovasc Med       Date:  2022-04-07

Review 8.  Nutraceutical, Dietary, and Lifestyle Options for Prevention and Treatment of Ventricular Hypertrophy and Heart Failure.

Authors:  Mark F McCarty
Journal:  Int J Mol Sci       Date:  2021-03-24       Impact factor: 5.923

9.  Association between apolipoprotein B/A1 ratio and coronary plaque vulnerability in patients with atherosclerotic cardiovascular disease: an intravascular optical coherence tomography study.

Authors:  Fuxue Deng; Danni Li; Lei Lei; Qiang Yang; Qing Li; Hongtao Wang; Jie Deng; Qiangsun Zheng; Wei Jiang
Journal:  Cardiovasc Diabetol       Date:  2021-09-15       Impact factor: 9.951

10.  Association of ABO blood groups and non-culprit plaque characteristics in acute coronary syndrome: an optical coherence tomography study.

Authors:  Liping Sun; Xiling Zhang; Rong Sun; Lin Lin; Lulu Li; Yinchun Zhu; Yan Wang; Bo Yu
Journal:  Ann Transl Med       Date:  2020-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.